Enduring Activity

Targeting HER2/3 in Advanced NSCLC: Where Are We and Where Are We Going?

Medical Crossfire®: Novel Applications of Liquid Biopsies Across Cancer Care

Enduring CME Activity From the June 22, 2020, Live Webcast: COVID-19 and Cancer Care: What Oncologists Need to Know Today: Focus on Managing Patients with Hematologic Malignancies

Clinical Briefings

Clinical Briefings™: Optimizing Management of Patients With PID Disorders- Challenges and Opportunities in Diagnosis and Treatment

Expert Perspectives in Relapsed/Refractory DLBCL: A Look to the Future of Care

Oncology Briefings&trade;

Oncology Briefings™: The Advent of Novel Treatment Approaches for SCLC

Oncology Consultations

Oncology Consultations®: Exploring Novel Agents and Future Directions in HER2-Positive Metastatic Breast Cancer

Onco-Nurse Academy™: Navigating Melanoma Management With Targeted Therapies and Immunotherapies

Medical Crossfire®

Medical Crossfire®: Improving Patient Outcomes in MDS Through Better Diagnosis, Risk Stratification, and New Treatment Options

Medical Crossfire®: How Can We Maximize Immuno-Oncology Strategies in Small Cell Lung Cancers?

Clinical Briefings™: Advances in Anti-VEGF Therapies for Neovascular Age-Related Macular Degeneration

Advances In&trade;

Advances In™ MDS and MPNs: Nursing Strategies for Disease and Anemia Management

<h2 style="text-align:center">Clinical Updates on the Rapid Advancements in COVID-19 Care: Vaccine Uptake and the Retail Pharmacist</h2>

<div style="text-align:center">An Online CE-accredited Article! 
&nbsp;</div>

<div style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px; text-align:center">This activity is supported by an educational grant from 
Janssen Therapeutics, Division of Janssen Products, LP.</div>
 
Faculty 
 
Miranda Wilhelm, PharmD 
Clinical Professor 
SIUE School of Pharmacy 
Department of Pharmacy Practice 
Edwardsville, Illinois 
 
Medical Reviewer 
 
Mary Barna Bridgeman, PharmD, BCPS, BCGP 
Clinical Professor 
Ernest Mario School of Pharmacy 
Rutgers, The State University of New Jersey 
Piscataway, New Jersey 
&nbsp;
<div style="margin-bottom:8pt; margin-left:0in; margin-right:0in; margin-top:0in; text-align:center">
<hr /></div>
 
Program Description 
The global COVID-19 pandemic has led to an unprecedented strain on the US health care system, and its rapid spread continues to pose a national threat, as it has climbed to the third leading cause of death in the United States after heart disease and cancer. The limited treatment options for COVID-19, coupled with its high rate of transmission, contribute to the large number of people infected and resultant morbidity and mortality. A global initiative is underway to develop a safe and effective COVID-19 vaccine. As frontline health care professionals, pharmacists will likely be involved in ensuring vaccine access and it&rsquo;s administration. Vaccine hesitancy is a long-standing health care issue and has only grown due to misinformation related to COVID-19. This educational activity will provide pharmacists with an understanding of the reasons for vaccine hesitancy as well as an in-depth review of the status of efforts to develop a COVID-19 vaccine including considerations for storage, administration, and adverse effect monitoring. 
 
Target audience:&nbsp;Retail pharmacists &nbsp; 
Type of activity:&nbsp;Knowledge 
Release date: January 13, 2021 
Expiration date: February 13, 2022 
Time to complete activity: 2.0 hours 
Fee: Free 
 
Educational Objectives 
At the completion of this activity, participants will be able to: 

<ul>
	<li>Describe the public health burden of COVID-19 and challenges in treatment and prevention</li>
	<li>Review the types of vaccines in development, their efficacy and safety, and the anticipated market launch timeline</li>
	<li>Recognize the role of the pharmacist and pharmacies in delivering COVID-19 vaccines to the population and in implementing strategies to overcome barriers and reduce vaccine hesitancy</li>
</ul>
 
<img alt="acpe" src="https://ptce.s3.amazonaws.com/_media/_eblast/ACPE_Large.jpg" style="float:left; height:59px; width:60px" />&nbsp;Pharmacy Times&nbsp;Continuing Education&trade; is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEU) under the ACPE universal activity number 0290-0000-21-001-H06-P. The activity is available for CE credit through February 13, 2022. 
 
 
Instructions for Completing the Activity and Receiving CPE Credit 
To receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date. 
&nbsp;
<hr /> 
Disclosures 
 
Miranda Wilhelm, PharmD, has no relevant financial relationships with commercial interests to disclose. 
 
 
Mary Barna Bridgeman, PharmD, BCPS, BCGP, has the following relevant financial relationship with a commercial interest to disclose: 
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Speakers Bureau: AstraZeneca 
 
Pharmacy Times&nbsp;Continuing Education&trade;&nbsp;Planning Staff&nbsp;&ndash; Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Rose Namissa, PharmD, BCPS; Brianna Schauer, MBA, PMP; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose. 
 
An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose. 
 
Educational Disclaimer 
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources. 
 
For questions about this internet CPE activity, please contact: 
<a href="mailto:ceinfo@pharmacytimes.com">ceinfo@pharmacytimes.com</a> 
Privacy Policy and Terms of Use Information: 
<a href="http://www.pharmacytimes.org/terms">www.pharmacytimes.org/terms</a> 
&nbsp;

Clinical Updates on the Rapid Advancements in COVID-19 Care: Vaccine Uptake and the Retail Pharmacist

<h2 style="text-align:center">Melatonin Supplementation in Circadian Rhythm Disorders and Sleep Regulation: The Role of the Retail Pharmacist</h2>

<div style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px; text-align:center">This activity is supported by an educational grant from 
Nature Made Nutritional Products</div>
 
Faculty 
 
Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP 
Clinical Associate Professor 
State University of New York at Buffalo School of Medicine 
Department of Psychiatry 
Director of Psychiatric Pharmacy Residency Programs 
State University of New York at Buffalo School of Pharmacy and Pharmaceutical Sciences 
Department of Pharmacy Practice 
Buffalo, New York 
&nbsp;
<div style="margin-bottom:8pt; margin-left:0in; margin-right:0in; margin-top:0in; text-align:center">
<hr /></div>
 
Program Description 
Melatonin supplements are commonly used in the United States, with recent statistics reporting its use in 3 million Americans for insomnia and other sleep disorders. Melatonin is one of many important neurohormones involved in the mediation of the sleep cycle and circadian rhythm. Sleep experts have promoted the use of melatonin over other traditional sleep pharmacotherapy, which has been associated with more serious potential risks. As front-line health care providers, retail pharmacists are in a pivotal position to educate patients about the role of melatonin and when it may be beneficial. This activity will review the regulation of sleep and provide practical counseling points for patients about the safe and proper use of melatonin supplements. 
 
Target Audience:&nbsp;Community Pharmacists 
Type of Activity:&nbsp;Application 
Release date: September 15, 2020 
Expiration date: September 15, 2021 
Time to complete activity: 2.0 hours 
Fee: Free 
 
Educational Objectives 
At the completion of this activity, participants will be able to: 

<ul>
	<li>Examine the physiological role of endogenous melatonin in regulating sleep and circadian rhythm</li>
	<li>Explore the use of exogenous melatonin supplements as a sleep aid, including the mechanism of action, dosing, and common adverse effects associated with melatonin supplements</li>
	<li>Compare and contrast the use of melatonin supplements versus other OTC and prescription sleep aids</li>
	<li>Identify the role of the pharmacist as a patient educator and patient advocate in counseling and in making clinical recommendations about melatonin supplements</li>
</ul>
 
<img alt="acpe" src="https://ptce.s3.amazonaws.com/_media/_eblast/ACPE_Large.jpg" style="float:left; height:59px; width:60px" />Pharmacy Times&nbsp;Continuing Education&trade; is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEU) under the ACPE universal activity number 0290-0000-20-245-H01-P. The activity is available for CE credit through September 15, 2021. 
 
 
Instructions for Completing the Activity and Receiving CPE Credit 
To receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date. 
&nbsp;
<hr /> 
Disclosures 
 
The following contributors have no relevant financial relationships with commercial interests to disclose: 
 
Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP 
 
Pharmacy Times&nbsp;Continuing Education&trade;&nbsp;Planning Staff&nbsp;&ndash; Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Dipti Desai, PharmD, CHCP; Kelly McCormick; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose. 
 
An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose. 
 
Educational Disclaimer 
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources. 
 
For questions about this internet CPE activity, please contact: 
<a href="mailto:ceinfo@pharmacytimes.com">ceinfo@pharmacytimes.com</a> 
Privacy Policy and Terms of Use Information: 
<a href="http://www.pharmacytimes.org/terms">www.pharmacytimes.org/terms</a> 
&nbsp;

Melatonin Supplementation in Circadian Rhythm Disorders and Sleep Regulation: The Role of the Retail Pharmacist